Abstract
Genetic risk for psychotic disorder may be expressed in part as sensitivity to the psychotomimetic effect of cannabis,1 but which genes underlie differential sensitivity remains unknown. An earlier study by Caspi and coworkers2 suggested that a functional Val/Met polymorphism in the gene encodingcatechol- O-methyltransferase (COMT) may mediate differential sensitivity to cannabis, with some support from 2 (semi)experimental studies assessing acute psychotomimetic effects of tetrahydrocannabinol (THC).3,4 However, a case-only study in 493 patients with a psychotic disorder did not support a COMT Val158Met × cannabis interaction.5

This publication has 51 references indexed in Scilit: